Literature DB >> 23670154

Isoniazid toxicity in a 5-year-old boy.

Michelle Science1, Shinya Ito, Ian Kitai.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23670154      PMCID: PMC3707995          DOI: 10.1503/cmaj.121732

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

Review 1.  Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

2.  Risk factors for isoniazid hepatotoxicity in children with latent TB and TB: difference from adults.

Authors:  Ilker Devrim; Ozgür Olukman; Demet Can; Ceyhun Dizdarer
Journal:  Chest       Date:  2010-03       Impact factor: 9.410

3.  A clinical approach to paediatric tuberculosis in Canada.

Authors:  Ian Kitai; Patricia Malloy
Journal:  Paediatr Child Health       Date:  2003-03       Impact factor: 2.253

4.  Twenty isoniazid-associated deaths in one state.

Authors:  T S Moulding; A G Redeker; G C Kanel
Journal:  Am Rev Respir Dis       Date:  1989-09

Review 5.  An official ATS statement: hepatotoxicity of antituberculosis therapy.

Authors:  Jussi J Saukkonen; David L Cohn; Robert M Jasmer; Steven Schenker; John A Jereb; Charles M Nolan; Charles A Peloquin; Fred M Gordin; David Nunes; Dorothy B Strader; John Bernardo; Raman Venkataramanan; Timothy R Sterling
Journal:  Am J Respir Crit Care Med       Date:  2006-10-15       Impact factor: 21.405

Review 6.  Drug-induced hepatotoxicity.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1995-10-26       Impact factor: 91.245

7.  Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic.

Authors:  C M Nolan; S V Goldberg; S E Buskin
Journal:  JAMA       Date:  1999-03-17       Impact factor: 56.272

8.  Severe isoniazid-associated liver injuries among persons being treated for latent tuberculosis infection - United States, 2004-2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-03-05       Impact factor: 17.586

9.  Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis.

Authors:  S R Salpeter
Journal:  West J Med       Date:  1993-11

10.  Isoniazid-related hepatic failure in children: a survey of liver transplantation centers.

Authors:  Steven S Wu; Catherine S Chao; Jorge H Vargas; Harvey L Sharp; Martín G Martín; Sue V McDiarmid; Frank R Sinatra; Marvin E Ament
Journal:  Transplantation       Date:  2007-07-27       Impact factor: 4.939

  10 in total
  3 in total

Review 1.  Epidemiology and clinical management of tuberculosis in children in Canada.

Authors:  Shaun K Morris; Anne-Marie Demers; Ray Lam; Lisa G Pell; Ryan Jp Giroux; Ian Kitai
Journal:  Paediatr Child Health       Date:  2015-03       Impact factor: 2.253

Review 2.  Diagnosis and management of pediatric tuberculosis in Canada.

Authors:  Ian Kitai; Shaun K Morris; Faisal Kordy; Ray Lam
Journal:  CMAJ       Date:  2017-01-09       Impact factor: 8.262

3.  Strengthening Tuberculosis Services for Children and Adolescents in Low Endemic Settings.

Authors:  Jeffrey R Starke; Connie Erkens; Nicole Ritz; Ian Kitai
Journal:  Pathogens       Date:  2022-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.